title: HIV clinical trial design for antiretroviral development: moving forward.
authors.affiliation: Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
authors.forename: Kirk M
authors.initials: KM
authors.lastname: Chan-Tack
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Struble
authors.forename: Nathalie
authors.initials: N
authors.lastname: Morgensztejn
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Murray
authors.forename: Roy
authors.initials: R
authors.lastname: Gulick
authors.forename: Ben
authors.initials: B
authors.lastname: Cheng
authors.forename: Ian
authors.initials: I
authors.lastname: Weller
authors.forename: Veronica
authors.initials: V
authors.lastname: Miller
mesh_terms: D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D018849:Controlled Clinical Trials as Topic / Q000379:methods; D015195:Drug Design; D004341:Drug Evaluation; D016903:Drug Monitoring; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D012107:Research Design
chemical_list: D044966:Anti-Retroviral Agents